- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02858544
Concussion in Motor Vehicle Accidents: The Concussion Identification Index (CIDI)
Studieoversigt
Status
Betingelser
- Hjerneskader
- TBI (traumatisk hjerneskade)
- Motorkøretøjsulykker
- Hjernerystelse
- Hjernekontusion
- Traumatisk hjerneskade med kortvarig bevidsthedstab
- Cerebral hjernerystelse
- Ulykker, Trafik
- Traumatisk hjerneskade med tab af bevidsthed
- Trafikulykker
- Kortikal kontusion
- Hjernerystelse mild
- Traumatic Brain Injury With no Loss of Consciousness
Intervention / Behandling
Detaljeret beskrivelse
This Phase 2 study, Concussion in Motor Vehicle Accidents - The Concussion Identification Index (CIDI), focuses on the psychometric properties of the relationship between acute injury events, i.e. head impact, loss of consciousness (LOC), and post-traumatic amnesia (PTA), commonly reported post-crash signs and symptoms, and neurocognitive outcomes.
Cohort 1 is the validation group and will be used to confirm the optimal cut-off score of the Concussion Identification Index (CIDI) with the score on the ImPACT.
Cohort 2 is the cross-validation group.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Massachusetts
-
Springfield, Massachusetts, Forenede Stater, 01105
- Clionsky Neuro Systems, Inc.
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Cohort 1 - Validation Group: Consecutive patients who presented for care between November 1, 2013 and December 31, 2014 at the MVA Center for Rehabilitation, a public health clinic in Springfield, MA which provides specialized outpatient auto accident treatment and rehabilitation
Cohort 2 - Cross Validation Group: Consecutive patients who presented for care between January 1, 2015 and June 30, 2016 at the MVA Center for Rehabilitation, a public health clinic in Springfield, MA
Beskrivelse
Inclusion Criteria:
- Patients injured in a motor-vehicle related accident
Exclusion Criteria:
- Age younger than 10 years old or older than 60 years of age
- Patients who presented for initial evaluation of injuries greater than 90 days after MVA occurred
- Patients who declined to take a computerized neurocognitive test battery
- Patients who were not fluent in either English or Spanish
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Group1 - Validation Group
n=890 patients seen and evaluated for possible concussion after a motor vehicle accident.
Patients with qualifying scores on the Concussion Identification Index will also complete the ImPACT.
|
Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms
Patient- completed computerized neurocognitive test battery
|
|
Group 2 - Cross Validation Group
n=900 patients seen and evaluated for possible concussion after a motor vehicle accident.
Patients with qualifying scores on the Concussion Identification Index will also complete the ImPACT.
|
Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms
Patient- completed computerized neurocognitive test battery
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Correlation - Concussion Identification Index score with ImPACT test score
Tidsramme: Within 90 days of the accident
|
Within 90 days of the accident
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient-completed one page questionnaire
Tidsramme: Within 90 days of the accident
|
The questionnaire is divided into two parts: The Injury Characteristics section: asks for a yes-no indication of whether 5 concussion-associated events/injuries occurred: striking the head, whiplash, loss of consciousness, being dazed, or having post-traumatic amnesia; and, whether or not the patient had already been given a diagnosis of concussion. The Concussive Symptoms section asks the patient to rate on a scale of 0-3 the presence and severity of 10 cognitive and emotional symptoms associated with a post-concussion diagnosis. The total numeric value for each patient is reported as an indexed score. |
Within 90 days of the accident
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Mitchell I Clionsky, Ph.D, Clionsky Neuro Systems Inc.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Neurologiske manifestationer
- Neuroadfærdsmæssige manifestationer
- Kraniocerebralt traume
- Traumer, nervesystemet
- Bevidsthedsforstyrrelser
- Hovedskader, Lukket
- Sår, ikke-gennemtrængende
- Hjerneskader
- Sår og skader
- Hjerneskader, traumatiske
- Bevidstløshed
- Hjernerystelse
- Kontusioner
- Hjernekontusion
Andre undersøgelses-id-numre
- C-MVA
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjerneskader
-
University of MinnesotaRekruttering
-
Virginia Polytechnic Institute and State UniversityTrukket tilbage
-
BraindexClinique de la SauvegardeAfsluttetAnæstesi | Brain MonitorFrankrig
-
Assistance Publique Hopitaux De MarseilleUkendt
-
National Institute of Mental Health (NIMH)AfsluttetKÆLEDYR | Brain Imaging | Cannabinoid | CB1Forenede Stater
-
GE HealthcareAfsluttetBrain Imaging | Billedbehandling af hele kroppenForenede Stater
-
Mayo ClinicAfsluttetBrain Imaging | Billedbehandling af hele kroppenForenede Stater
-
Tang-Du HospitalIkke rekrutterer endnuPsykisk lidelse | Sociale medier | Brain Imaging
-
University Hospital TuebingenAfsluttetFunktionel dyspepsi | Mad | Brain ImagingTyskland
-
University of MichiganAfsluttetÆndringer i Brain Network ConnectivityForenede Stater
Kliniske forsøg med The Concussion Identification Index
-
Hospices Civils de LyonAfsluttetAmbulant pleje | Beredskab, Sygehus | Sundhedstjenester for ældreFrankrig
-
Gaziosmanpasa Research and Education HospitalIkke rekrutterer endnuSlidgigt | Rheumatoid arthritis
-
Assiut UniversityAfsluttetInflammatoriske tarmsygdomme | Seksuelle funktionsforstyrrelserEgypten
-
Medical University of LublinAfsluttet
-
Sanjay Gupta PhDAfsluttetFase I prostatakræft | Stadie IIA prostatakræft | Stadie IIB prostatakræftForenede Stater
-
Tampere UniversityTurku University Hospital; Helsinki University Central Hospital; Oulu University... og andre samarbejdspartnereAktiv, ikke rekrutterendeDupuytren KontrakturFinland